Is rituximab indicated in acquired TTP

Drugs / By

Is rituximab indicated in acquired TTP?

Yes. Rituximab is an anti-CD20 monoclonal antibody.

Its use in TTP is mainly indicated in adult TTP patients who are refractory to plasmapheresis and corticosteroids and in patients who have a relapsing course.

Related Posts

  • Rituximab

    What is Rituximab Rituximab is a CD20-directed cytolytic antibody used to treat adults with non-Hodgkin…

  • ICU acquired weakness

    What is ICU acquired weakness?  It is weakness acquired in the ICU, which is due…

  • How is TTP diagnosed

    How is TTP diagnosed What tests can be used to help diagnose TTP? In hereditary…

  • Chronic acquired demyelinating polyneuropathies

    What are the chronic acquired demyelinating polyneuropathies? CIDPCIDP variants: CIDP with central nervous system (CNS)…

Related Posts:

SIGN -UP NOW

Subcribe now to get the latest health tips and medical content straight to your inbox

 

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856